相关实验视频
Updated: Jul 12, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
我们可以通过干预CKD-MBD生物标志物来逆转动脉硬吗?
1Amsterdam University Medical Centres, Nephrology, Amsterdam, The Netherlands.
Clinical kidney journal
|November 2, 2023
概括
慢性病 (CKD) 增加了心血管风险,部分原因是动脉硬. 本综述研究了CKD-MBD矿物质和激素失衡如何严重影响动脉硬,发现是关键因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 慢性病 (CKD) 与心血管风险增加有关,主要受到动脉硬的影响.
- 在CKD中矿物质和激素失衡,称为CKD-MBD (CKD-矿物质和骨疾病),与血管化和动脉硬有关.
研究的目的:
- 审查,酸盐,副甲状腺激素 (PTH),维生素D,和FGF23的短期变化对CKD患者动脉硬性的急性影响.
- 为了区分直接影响大动脉硬与通过血管化介导的间接影响.
主要方法:
- 对观察性研究和干预性试验进行系统审查,评估动脉硬度,主要使用脉冲波速度.
- 分析涉及PTH输液,模仿剂使用,手术和维生素D给药等干预措施的研究.
主要成果:
- 升高的水平与动脉硬度恶化有关.
- 酸盐,PTH,和FGF23对大动脉硬度没有明显的直接急性影响.
- 关于维生素D直接影响的证据是相互矛盾的,需要进一步调查.
结论:
- 虽然血管化是CKD中动脉硬的主要原因,但急性矿物质和激素失调,特别是,可以直接影响动脉硬.
- 需要进一步的研究来澄清特定CKD-MBD组件在动脉硬性上独立于化的直接作用.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease II: Clinical Manifestations
11
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11
Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17

